Showing results (361-370 of 390) with videos related to
Sort By:
Pageof 39
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 14, 2015
Patients with acute liver failure listed for superurgent liver transplantation in France: reevaluation of the Clichy-Villejuif criteriaPhilippe Ichai, Camille Legeai, Claire Francoz, et al.JHEP Reports : Innovation in Hepatology|April 1, 2022
R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantationCharlotte Costentin, Federico Piñero, Helena Degroote, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2019
Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III StudyJulien Edeline, Meher Benabdelghani, Aurélie Bertaut, et al.JHEP Reports : Innovation in Hepatology|January 24, 2023
AFP score and metroticket 2.0 perform similarly and could be used in a "within-ALL" clinical decision toolFederico Piñero, Charlotte Costentin, Helena Degroote, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 4, 2014
Tumour size over 3 cm predicts poor short-term outcomes after major liver resection for hilar cholangiocarcinoma. By the HC-AFC-2009 groupJean Marc Regimbeau, David Fuks, Patrick Pessaux, et al.JHEP Reports : Innovation in Hepatology|September 6, 2021
International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteriaHelena Degroote, Federico Piñero, Charlotte Costentin, et al.Liver International : Official Journal of the International Association for the Study of the Liver|August 4, 2022
Liver transplantation for NAFLD cirrhosis: Age and recent coronary angioplasty are major determinants of survivalFrançois Villeret, Sébastien Dharancy, Domitille Erard, et al.JHEP Reports : Innovation in Hepatology|February 28, 2023
Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosisFrançois Villeret, Sébastien Dharancy, Domitille Erard, et al.The Lancet. Gastroenterology & Hepatology|November 9, 2020
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trialEtienne Garin, Lambros Tselikas, Boris Guiu, et al.Cell Reports|December 31, 2024
Cyclin O controls entry into the cell-cycle variant required for multiciliated cell differentiationMichella Khoury Damaa, Jacques Serizay, Rémi Balagué, et al.Pageof 39